We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Announces “Stalking Horse” Agreement for the Sale of Zokinvy® (lonafarnib) Patient Access to Zokinvy® to Continue Uninterrupted PALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Eiger...
Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan PR Newswire PALO ALTO...
Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split PR Newswire PALO ALTO, Calif., Jan. 4, 2024 PALO ALTO, Calif., Jan. 4, 2024 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | -3.645 | -67.8770949721 | 5.37 | 5.37 | 1.1 | 647430 | 1.75433545 | CS |
12 | -4.385 | -71.767594108 | 6.11 | 8.2672 | 1.1 | 142705 | 2.05585678 | CS |
26 | -7.347 | -80.9854497354 | 9.072 | 14.33697 | 1.1 | 201118 | 6.18332349 | CS |
52 | -29.175 | -94.4174757282 | 30.9 | 43.35 | 1.1 | 298812 | 16.64719907 | CS |
156 | -250.875 | -99.3171021378 | 252.6 | 300.639 | 1.1 | 425280 | 122.38121572 | CS |
260 | -327.675 | -99.4763205829 | 329.4 | 474.6 | 1.1 | 380300 | 185.54670395 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions